688520.SHG Sinocelltech Group Ltd

Healthcare Biotechnology Shanghai Stock Exchange
32.63 CNY
Close of Nov 5, 2026
28.86 52.49
Market cap
CNY 15.3B
P/E
-
P/B
22.45x
ROE
-115.5%
Dividend yield
0.73%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 688520.SHG undervalued?

Graham number

The Graham number of Sinocelltech Group Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sinocelltech Group Ltd fundamental analysis

No fundamental analysis for Sinocelltech Group Ltd yet.

Sinocelltech Group Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sinocelltech Group Ltd

Sinocelltech Group Limited, a biopharmaceutical company, engages in the research, development, and production of recombinant proteins, antibody drugs, viral infections, and vaccines in China. The company offers Anjiayin, a third-generation recombinant coagulation factor VIII product for the treatment of hemophilia A; Anpingxi, an anti-CD20 monoclonal antibody for the treatment of CD20-positive diffuse large B-cell non-Hodgkin's lymphoma; Anjiarun, an adalimumab biosimilar fo…

Full company profile